miR-299a-5p: a novel mediator of fibrosis in diabetic kidney disease
miR-299a-5p: a novel mediator of fibrosis in diabetic kidney disease
miR-299a-5p：糖尿病肾病纤维化的新型介质
批准号：
475456
负责人：
Nmecha Ifeanyi K
金额：
$7.65万
依托单位：
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-11-01 至 2025-11-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
As of 2020, Diabetes Canada estimated 11.2 million Canadians live with some form of diabetes, with a rise to 13.5 million by 2030. It was also estimated that the health care cost of treating diabetes and its complications was ~C$3.8b, with a projected ris
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
